Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC

被引：1
|
作者：
Ochoa-de-Olza, Maria [1 ,2 ]
Bourhis, Jean [3 ]
Coukos, George [1 ,2 ]
Herrera, Fernanda G. [1 ,2 ,3 ]
机构：
[1] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, Lausanne, Switzerland
[2] Lausanne Univ Hosp, Dept Oncol, Immunooncol Serv, CH-1011 Lausanne, Switzerland
[3] Lausanne Univ Hosp, Dept Oncol, Radiat Oncol Serv, CH-1011 Lausanne, Switzerland
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E157 / E157
页数：1
相关论文
共 50 条
  • [1] Radiotherapy Sensitizes Head and Neck Tumors to PD-L1 Immune Checkpoint Blockade
    Oweida, A. J.
    Calame, D.
    Lennon, S.
    Bhatia, S.
    Raben, D.
    Clambey, E.
    Heasley, L.
    Nemenoff, R.
    Karam, S. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S202 - S202
  • [2] Radiotherapy and PD-L1 inhibition in metastatic NSCLC
    De Ruysscher, Dirk
    LANCET ONCOLOGY, 2017, 18 (07): : 840 - 842
  • [3] Sitravatinib plus tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic NSCLC
    Gao, B.
    Ma, Z.
    Yu, X.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Zhou, Q.
    Chu, Q.
    Pan, H.
    Cui, J.
    Chen, C.
    Xiang, X.
    Fei, C.
    Yang, L.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2021, 32 : S998 - S998
  • [4] PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas
    Wang, Yi
    Wu, Ling
    Tian, Chen
    Zhang, Yizhuo
    ANNALS OF HEMATOLOGY, 2018, 97 (02) : 229 - 237
  • [5] PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas
    Yi Wang
    Ling Wu
    Chen Tian
    Yizhuo Zhang
    Annals of Hematology, 2018, 97 : 229 - 237
  • [6] PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy
    Cottrell, Tricia R.
    Taube, Janis M.
    CANCER JOURNAL, 2018, 24 (01): : 41 - 46
  • [7] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [8] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [9] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [10] Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
    Ilcus, Cristina
    Bagacean, Cristina
    Tempescul, Adrian
    Popescu, Cristian
    Parvu, Andrada
    Cenariu, Mihai
    Bocsan, Corina
    Zdrenghea, Mihnea
    ONCOTARGETS AND THERAPY, 2017, 10 : 2349 - 2363
12345